BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 27288408)

  • 1. Glycosynthase Mutants of Endoglycosidase S2 Show Potent Transglycosylation Activity and Remarkably Relaxed Substrate Specificity for Antibody Glycosylation Remodeling.
    Li T; Tong X; Yang Q; Giddens JP; Wang LX
    J Biol Chem; 2016 Aug; 291(32):16508-18. PubMed ID: 27288408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation and Comparative Kinetic Analysis of New Glycosynthase Mutants from Streptococcus pyogenes Endoglycosidases for Antibody Glycoengineering.
    Tong X; Li T; Li C; Wang LX
    Biochemistry; 2018 Sep; 57(35):5239-5246. PubMed ID: 30102520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-pot enzymatic glycan remodeling of a therapeutic monoclonal antibody by endoglycosidase S (Endo-S) from Streptococcus pyogenes.
    Tong X; Li T; Orwenyo J; Toonstra C; Wang LX
    Bioorg Med Chem; 2018 Apr; 26(7):1347-1355. PubMed ID: 28789910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endo-F3 Glycosynthase Mutants Enable Chemoenzymatic Synthesis of Core-fucosylated Triantennary Complex Type Glycopeptides and Glycoproteins.
    Giddens JP; Lomino JV; Amin MN; Wang LX
    J Biol Chem; 2016 Apr; 291(17):9356-70. PubMed ID: 26966183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoenzymatic glycoengineering of intact IgG antibodies for gain of functions.
    Huang W; Giddens J; Fan SQ; Toonstra C; Wang LX
    J Am Chem Soc; 2012 Jul; 134(29):12308-18. PubMed ID: 22747414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of efficient mutants of endoglycosidase from Streptococcus pyogenes and their application in a novel one-pot transglycosylation reaction for antibody modification.
    Iwamoto M; Sekiguchi Y; Nakamura K; Kawaguchi Y; Honda T; Hasegawa J
    PLoS One; 2018; 13(2):e0193534. PubMed ID: 29474426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-specific immobilization of endoglycosidases for streamlined chemoenzymatic glycan remodeling of antibodies.
    Li T; Li C; Quan DN; Bentley WE; Wang LX
    Carbohydr Res; 2018 Mar; 458-459():77-84. PubMed ID: 29475193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of a Mutant Mucor hiemalis Endoglycosidase That Acts on Core-fucosylated N-Glycans.
    Katoh T; Katayama T; Tomabechi Y; Nishikawa Y; Kumada J; Matsuzaki Y; Yamamoto K
    J Biol Chem; 2016 Oct; 291(44):23305-23317. PubMed ID: 27629418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remarkable transglycosylation activity of glycosynthase mutants of endo-D, an endo-β-N-acetylglucosaminidase from Streptococcus pneumoniae.
    Fan SQ; Huang W; Wang LX
    J Biol Chem; 2012 Mar; 287(14):11272-81. PubMed ID: 22318728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutants of Mucor hiemalis endo-beta-N-acetylglucosaminidase show enhanced transglycosylation and glycosynthase-like activities.
    Umekawa M; Huang W; Li B; Fujita K; Ashida H; Wang LX; Yamamoto K
    J Biol Chem; 2008 Feb; 283(8):4469-79. PubMed ID: 18096701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced transglycosylation activity of an Endo-F3 mutant by ligand-directed localization.
    Zou X; Liu Z; Liu L; Shi W; Li W; Guo Z; Tang F; Huang W
    Org Biomol Chem; 2022 Apr; 20(15):3086-3095. PubMed ID: 35166761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of glycosynthases with broad glycan specificity for the efficient glyco-remodeling of antibodies.
    Shivatare SS; Huang LY; Zeng YF; Liao JY; You TH; Wang SY; Cheng T; Chiu CW; Chao P; Chen LT; Tsai TI; Huang CC; Wu CY; Lin NH; Wong CH
    Chem Commun (Camb); 2018 Jun; 54(48):6161-6164. PubMed ID: 29809215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoenzymatic Glycan Remodeling of Natural and Recombinant Glycoproteins.
    Yang Q; Wang LX
    Methods Enzymol; 2017; 597():265-281. PubMed ID: 28935106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoenzymatic Glyco-engineering of Monoclonal Antibodies.
    Giddens JP; Wang LX
    Methods Mol Biol; 2015; 1321():375-87. PubMed ID: 26082235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoenzymatic Defucosylation of Therapeutic Antibodies for Enhanced Effector Functions Using Bacterial α-Fucosidases.
    Li C; Li T; Wang LX
    Methods Mol Biol; 2018; 1827():367-380. PubMed ID: 30196507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycosynthases enable a highly efficient chemoenzymatic synthesis of N-glycoproteins carrying intact natural N-glycans.
    Huang W; Li C; Li B; Umekawa M; Yamamoto K; Zhang X; Wang LX
    J Am Chem Soc; 2009 Feb; 131(6):2214-23. PubMed ID: 19199609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycan Remodeling of Human Erythropoietin (EPO) Through Combined Mammalian Cell Engineering and Chemoenzymatic Transglycosylation.
    Yang Q; An Y; Zhu S; Zhang R; Loke CM; Cipollo JF; Wang LX
    ACS Chem Biol; 2017 Jun; 12(6):1665-1673. PubMed ID: 28452462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosynthase activity of Bacillus licheniformis 1,3-1,4-beta-glucanase mutants: specificity, kinetics, and mechanism.
    Faijes M; Pérez X; Pérez O; Planas A
    Biochemistry; 2003 Nov; 42(45):13304-18. PubMed ID: 14609341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycoengineering of antibody (Herceptin) through yeast expression and in vitro enzymatic glycosylation.
    Liu CP; Tsai TI; Cheng T; Shivatare VS; Wu CY; Wu CY; Wong CH
    Proc Natl Acad Sci U S A; 2018 Jan; 115(4):720-725. PubMed ID: 29311294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EndoS2 is a unique and conserved enzyme of serotype M49 group A Streptococcus that hydrolyses N-linked glycans on IgG and α1-acid glycoprotein.
    Sjögren J; Struwe WB; Cosgrave EF; Rudd PM; Stervander M; Allhorn M; Hollands A; Nizet V; Collin M
    Biochem J; 2013 Oct; 455(1):107-18. PubMed ID: 23865566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.